Literature DB >> 20153969

Outcome following splenectomy in cats.

Sebastian S N Gordon1, Janet K McClaran, Philip J Bergman, Serena M Liu.   

Abstract

No studies have yet examined whether there are prognostic factors for survival for cats undergoing splenectomies. The medical records of 19 cats that had complete splenectomy were reviewed for information on preoperative, intraoperative, and postoperative factors. The most common presenting signs were a palpable abdominal mass in 58% and anorexia in 47% of the cats. Mast cell tumors were the most common reason for splenectomy and were found in 10/19 cats (53%); followed by hemangiosarcoma in 4/19 (21%); and lymphoma in 2/19 (11%). The Kaplan-Meier median survival time (MST) was 197 days, with a range from 2 days to 1959 days. Three cats were noted to have preoperative weight loss, and this was the only factor that had prognostic significance for survival following surgery. For cats with weight loss the MST was 3 days, for cats with no weight loss noted the MST was 293 days (P=0.008). Copyright 2009 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153969     DOI: 10.1016/j.jfms.2009.09.005

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Secondary inappropriate polycythemia with splenic hemangiosarcoma in a young adult cat.

Authors:  Kyoung Won Seo; Hwaran Hong; Sung-Ah An; Jung Keun Lee; Robert Rebhun
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

Review 2.  Vaccination of Immunocompromised Cats.

Authors:  Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

3.  Use of doxorubicin chemotherapy following debulking surgery in the treatment of a cat with mesenteric hemangiosarcoma.

Authors:  Kerry L Simon; Matthew R Cook; Brian D Husbands; Mackenzie E Long; Jessica A Hokamp; Timothy H Helms; Heather R Shive; Sarah Lumbrezer Johnson; Eric Hostnik; Laura E Selmic
Journal:  JFMS Open Rep       Date:  2022-09-15

4.  Giant splenic myelolipoma in a cat with hyperthyroidism.

Authors:  Kerry E Rolph; Beatriz Vidana; Elinor Field
Journal:  JFMS Open Rep       Date:  2022-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.